These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 17069561

  • 1. Repeated bilateral retrobulbar injection of botulinum toxin in a blind patient with retinitis pigmentosa and incapacitating nystagmus.
    Devogelaere T, Gobin C, Casaer P, Spileers W.
    Binocul Vis Strabismus Q; 2006; 21(4):235-8. PubMed ID: 17069561
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin- an effective treatment for acquired nystagmus with oscillopsia.
    Menon GJ, Thaller VT.
    Eye (Lond); 2002 Nov; 16(6):804-6. PubMed ID: 12439689
    [No Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J.
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [Abstract] [Full Text] [Related]

  • 4. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 5. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
    Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B.
    Urology; 2006 Dec; 68(6):1193-7. PubMed ID: 17141831
    [Abstract] [Full Text] [Related]

  • 6. The use of onabotulinum toxin A in the treatment of see-saw nystagmus.
    Cestari DM, Chan K, Tajouri N, Rizzo JF.
    J Pediatr Ophthalmol Strabismus; 2010 Jul 22; 47 Online():e1-3. PubMed ID: 21158362
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of nystagmus using injections of botulinum toxins into the eye muscles].
    Crone RA, de Jong PT, Notermans G.
    Klin Monbl Augenheilkd; 1984 Mar 22; 184(3):216-7. PubMed ID: 6727239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Repeated botulinum toxin type A injections to treat patients with Frey syndrome.
    de Bree R, Duyndam JE, Kuik DJ, Leemans CR.
    Arch Otolaryngol Head Neck Surg; 2009 Mar 22; 135(3):287-90. PubMed ID: 19289708
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Re: Karsenty G, Reitz A, Lindemann G, et al. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity (Urology 68:1193-1197, 2006).
    Kadi N.
    Urology; 2008 Oct 22; 72(4):951-2. PubMed ID: 18926254
    [No Abstract] [Full Text] [Related]

  • 12. Botulinum toxin for recurrent anal fissure following lateral internal sphincterotomy.
    Brisinda G, Cadeddu F, Brandara F, Marniga G, Vanella S, Nigro C, Maria G.
    Br J Surg; 2008 Jun 22; 95(6):774-8. PubMed ID: 18425796
    [Abstract] [Full Text] [Related]

  • 13. Subconjunctival botulinum toxin injection.
    Olver J.
    Ophthalmology; 2003 Nov 22; 110(11):2262-3. PubMed ID: 14597547
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA, Buwalda J.
    J Laryngol Otol; 2009 Apr 22; 123(4):412-7. PubMed ID: 18588738
    [Abstract] [Full Text] [Related]

  • 16. The use of botulinum toxin in the treatment of a parotid duct injury during Mohs surgery and review of management options.
    Krishnan RS, Clark DP, Donnelly HB.
    Dermatol Surg; 2009 Jun 22; 35(6):941-7. PubMed ID: 19397665
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P, Timon C.
    J Laryngol Otol; 2008 Jan 22; 122(1):52-6. PubMed ID: 17470307
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J.
    J Drugs Dermatol; 2009 May 22; 8(5):439-44. PubMed ID: 19537366
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.